55344-28-0

Basic information

• Product Name: 1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole
• Synonyms: 1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole
• CAS NO: 55344-28-0
• Molecular Weight: 227.309
• Mol File: 55344-28-0.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: 1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole(55344-28-0)
• EPA Substance Registry System: 1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole(55344-28-0)

Safety Data

• Hazardous Substances Data: 55344-28-0(Hazardous Substances Data)

Usage

Chemical class

Heterocyclic compound

Explanation

It contains a pyrazino and pyrido ring system, which are both heterocyclic structures.

Explanation

The compound has a multi-ring structure with various functional groups and atoms.

Explanation

The unique structure of the compound suggests that it may have biological activity, particularly in the field of neurological and psychiatric disorders.

Explanation

The compound's structure allows it to potentially interact with neurotransmitter systems in the brain, which could have implications for its medicinal properties.

Explanation

Due to its potential bioactivity and interaction with neurotransmitter systems, this compound may have pharmaceutical potential, particularly in the treatment of neurological and psychiatric disorders.

Explanation

More research is needed to fully understand the compound's medicinal properties, biological activities, and potential therapeutic applications.

Explanation

If the compound's potential medicinal properties and biological activities are confirmed through further research, it could lead to the development of new therapeutic agents for various health conditions.

Explanation

The information provided is based on the compound's structure and potential properties, but further research is needed to confirm its effectiveness and safety as a therapeutic agent.

Molecular structure

Complex

Potential bioactivity

Yes

Interaction with neurotransmitter systems

Possible

Pharmaceutical potential

High

Further research

Required

Development of new therapeutic agents

Potential

Current state of research

Preliminary

Downstream Products

• 77294-04-3 2-[3-(4-Fluoro-phenoxy)-propyl]-1,2,3,4,6,7,12,12a-octahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole 
• 79108-57-9 4-Chloro-N-[2-(7-methyl-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-benzamide 
• 79108-56-8 1-(4-Fluoro-phenyl)-4-(7-methyl-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-butan-1-one 
• 79108-62-6 2-Benzyl-7-propyl-1,2,3,4,6,7,12,12a-octahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole 
• 79108-54-6 2-Benzyl-7-methyl-1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole 
• 72593-14-7 4-Chloro-N-[2-(3,4,6,7,12,12a-hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-benzamide 
• 72593-16-9 N-[2-(3,4,6,7,12,12a-Hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-3,4,5-trimethoxy-benzamide 
• 72593-26-1 N-[2-(3,4,6,7,12,12a-Hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-terephthalamic acid ethyl ester 
• 72593-31-8 N-[2-(3,4,6,7,12,12a-Hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-4-methanesulfonyl-benzamide 
• 72593-20-5 N-[2-(3,4,6,7,12,12a-Hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-3-nitro-benzamide 
• 72593-22-7 2-β-(4'-Nitrobenzoyl)aminoethyl-1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4-b>indole 
• 72593-17-0 N-[2-(3,4,6,7,12,12a-Hexahydro-1H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-ethyl]-2-nitro-benzamide 
• 72593-08-9 Ethamidindole 
• 91119-35-6 2-β-(4-Nitrobenzylideno)ethyl-1,2,3,4,6,7,12,12a-octahydropyrazino<2',1':6,1>pyrido<3,4>indole